As-Needed Albuterol–Budesonide in Mild Asthma
LaForce C, Albers F, Danilewicz A et al. N Engl J Med. 2025 May 19. doi: 10.1056/NEJMoa2504544. Abstract Background As-needed use of albuterol–budesonide has been shown to result in a…
LaForce C, Albers F, Danilewicz A et al. N Engl J Med. 2025 May 19. doi: 10.1056/NEJMoa2504544. Abstract Background As-needed use of albuterol–budesonide has been shown to result in a…
Fang LC, Wang JY. J Microbiol Immunol Infect. 2025 May 8:S1684-1182(25)00088-X. doi: 10.1016/j.jmii.2025.04.007. Abstract Background Respiratory syncytial virus (RSV) infection may induce asthma and allergic sensitisation. RSV immunoprophylaxis can reduce…
Garcia-Aymerich, Judith et al. The Lancet Respiratory Medicine, Online first May 15, 2025 Open access Summary Background Lung function is a key determinant of health, but current knowledge on lung…
Gao, Y., Liang, B., Su, X. et al. BMC Pulm Med 25, 228 (2025). https://doi.org/10.1186/s12890-025-03690-1 AbstractBackgroundAccess to spirometry remains limited due to the expense and inconvenience of stationary laboratory spirometers, which may compromise…
Darin Elabbasy, Timo Clemens, Natalia Rachwal, Nivya John, Hsin-Yi Weng, Lynette Hart, Locksley L. McV. Messam. Journal of Allergy and Hypersensitivity Diseases,Volume 5,2025,100035, https://doi.org/10.1016/j.jahd.2025.100035. Highlights Abstract Background Hypersensitivity pneumonitis secondary…
Tian, J., Zhang, Q., Peng, M. et al. Respir Res 26, 173 (2025). https://doi.org/10.1186/s12931-025-03242-5 Abstract Background Globally, chronic respiratory diseases have become the third leading cause of death, including chronic obstructive pulmonary disease…
Twohig H, Franklin L, Carroll W, Corp N, Jackson E, Mallen C, Ruan B, Yapp L, Der Windt DV, Smith J. Paediatr Respir Rev. 2025 Apr 16:S1526-0542(25)00036-3. doi: 10.1016/j.prrv.2025.04.005. Abstract…
World Asthma Day is around the corner and the #EFACommunity is joining forces to call for better asthma care across Europe. Access to early diagnosis, the right treatment and proper education…
In celebration of World Asthma Day 2025, the Global Initiative for Asthma (GINA) has chosen the theme “Make Inhaled Treatments Accessible for ALL”. GINA emphasizes the need to ensure that people with…